Frauke Zipp
#155,219
Most Influential Person Now
Researcher
Frauke Zipp's AcademicInfluence.com Rankings
Frauke Zippbiology Degrees
Biology
#11913
World Rank
#15347
Historical Rank
Molecular Biology
#1884
World Rank
#1913
Historical Rank
Neuroscience
#1969
World Rank
#2025
Historical Rank
Download Badge
Biology
Why Is Frauke Zipp Influential?
(Suggest an Edit or Addition)Frauke Zipp's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) (2511)
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) (1170)
- Multiple Sclerosis Severity Score (2005) (642)
- Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) (589)
- Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database (2012) (546)
- Sirt1 contributes critically to the redox-dependent fate of neural progenitors (2008) (460)
- Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System. (2015) (448)
- The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases (2006) (352)
- Green Tea Epigallocatechin-3-Gallate Mediates T Cellular NF-κB Inhibition and Exerts Neuroprotection in Autoimmune Encephalomyelitis1 (2004) (326)
- Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) (2000) (319)
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis (2018) (319)
- Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica (2008) (308)
- In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. (2010) (299)
- Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation (2005) (293)
- Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin (2003) (289)
- Class II HLA interactions modulate genetic risk for multiple sclerosis (2015) (262)
- MR-elastography reveals degradation of tissue integrity in multiple sclerosis (2010) (260)
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis (2018) (224)
- Immunoneuropsychiatry — novel perspectives on brain disorders (2019) (216)
- Neuronal Damage in Autoimmune Neuroinflammation Mediated by the Death Ligand TRAIL (2005) (215)
- Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica (2007) (211)
- Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. (2004) (211)
- Perivascular spaces--MRI marker of inflammatory activity in the brain? (2008) (210)
- TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis (2003) (202)
- Multiple sclerosis – candidate mechanisms underlying CNS atrophy (2010) (201)
- Neuronal damage in brain inflammation. (2007) (189)
- Microglia–blood vessel interactions: a double-edged sword in brain pathologies (2016) (188)
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis (2014) (173)
- Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study (2011) (171)
- Perivascular microglia promote blood vessel disintegration in the ischemic penumbra (2015) (166)
- Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis (2009) (165)
- Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. (2013) (149)
- Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells1 (2002) (147)
- Molecular mechanisms linking neuroinflammation and neurodegeneration in MS (2014) (146)
- Direct Impact of T Cells on Neurons Revealed by Two-Photon Microscopy in Living Brain Tissue (2004) (146)
- Activation of Microglial Poly(ADP-Ribose)-Polymerase-1 by Cholesterol Breakdown Products during Neuroinflammation (2003) (145)
- No increase in demyelinating diseases after hepatitis B vaccination (1999) (142)
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis (2019) (128)
- MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. (2015) (124)
- Neuronal injury in chronic CNS inflammation. (2010) (122)
- Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system (2009) (121)
- Lack of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand But Presence of Its Receptors in the Human Brain (2002) (121)
- Autoregulation of Th1-mediated inflammation by twist1 (2008) (119)
- Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis (2008) (117)
- Neurodegeneration in autoimmune CNS inflammation (2010) (116)
- Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. (2003) (116)
- DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis (2018) (116)
- The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility (2017) (113)
- Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients (2010) (109)
- IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments. (2014) (109)
- Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis (2017) (108)
- Understanding the Role of T Cells in CNS Homeostasis. (2016) (105)
- Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation (2016) (104)
- Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo (2015) (102)
- Graph Theoretical Framework of Brain Networks in Multiple Sclerosis: A Review of Concepts (2017) (99)
- Expanding two-photon intravital microscopy to the infrared by means of optical parametric oscillator. (2010) (98)
- Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis. (2013) (98)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (98)
- MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. (2015) (95)
- Genetic control of multiple sclerosis: Increased production of lymphotoxin and tumor necrosis factor‐α by HLA‐DR2+ T cells (1995) (88)
- Neurons as targets for T cells in the nervous system (2013) (88)
- Rapid alterations of cell cycle control proteins in human T lymphocytes in microgravity (2012) (86)
- Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology? (2016) (85)
- Correlation of self-assessed fatigue and alertness in multiple sclerosis (2010) (85)
- Neurodegeneration in multiple sclerosis: novel treatment strategies (2012) (84)
- Familial effects on the clinical course of multiple sclerosis (2006) (82)
- Cytotoxic CD8+ T Cell–Neuron Interactions: Perforin-Dependent Electrical Silencing Precedes But Is Not Causally Linked to Neuronal Cell Death (2009) (80)
- The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis (1995) (80)
- Increased serum levels of soluble CD95 (APO‐1/Fas) in relapsing‐remitting multiple sclerosis (1998) (80)
- Frequency of blood CX3CR1‐positive natural killer cells correlates with disease activity in multiple sclerosis patients (2005) (79)
- Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization. (2009) (76)
- Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis (2017) (75)
- Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis (2011) (75)
- Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation (2011) (75)
- Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system. (1999) (75)
- Escalating immunotherapy of multiple sclerosis--new aspects and practical application. (2004) (73)
- TRAIL limits excessive host immune responses in bacterial meningitis. (2007) (73)
- ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. (2009) (73)
- IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci (2010) (72)
- BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions (2011) (71)
- Attention Network Test reveals alerting network dysfunction in multiple sclerosis (2010) (71)
- Apoptosis in multiple sclerosis (2000) (71)
- Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study (2010) (70)
- NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke. (2019) (70)
- Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. (1997) (68)
- Parallelized TCSPC for Dynamic Intravital Fluorescence Lifetime Imaging: Quantifying Neuronal Dysfunction in Neuroinflammation (2013) (67)
- Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells (2000) (67)
- PML risk stratification using anti-JCV antibody index and L-selectin (2016) (67)
- Astrocyte-induced T cell elimination is CD95 ligand dependent (2002) (66)
- Blockade of chemokine signaling in patients with multiple sclerosis (2006) (66)
- Encephalopathy, visual disturbance and hearing loss—recognizing the symptoms of Susac syndrome (2009) (66)
- Neural Cell Adhesion Molecule Polysialylation Enhances the Sensitivity of Embryonic Stem Cell‐Derived Neural Precursors to Migration Guidance Cues (2007) (65)
- Atorvastatin Induces T Cell Anergy via Phosphorylation of ERK11 (2005) (64)
- Impact of HMG-CoA reductase inhibition on brain pathology. (2007) (64)
- Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS (2016) (63)
- Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy (2007) (61)
- MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. (2013) (61)
- Analyses of phenotypic and functional characteristics of CX3CR1‐expressing natural killer cells (2011) (60)
- The potential of serum neurofilament as biomarker for multiple sclerosis (2021) (60)
- The problems and promises of research into human immunology and autoimmune disease (2012) (59)
- CNS‐irrelevant T‐cells enter the brain, cause blood–brain barrier disruption but no glial pathology (2007) (59)
- Monitoring B-cell repopulation after depletion therapy in neurologic patients (2018) (59)
- Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis (1998) (59)
- Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis (2017) (59)
- Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis (2009) (59)
- Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. (1997) (57)
- Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation (2009) (57)
- IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis (2019) (56)
- The role of TRAIL/TRAIL receptors in central nervous system pathology. (2007) (56)
- Cerebral blood perfusion changes in multiple sclerosis (2007) (55)
- Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging (2019) (54)
- Mouse model mimics multiple sclerosis in the clinico‐radiological paradox (2007) (54)
- Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS (2018) (53)
- New insights into adaptive immunity in chronic neuroinflammation. (2007) (52)
- Structural correlates for fatigue in early relapsing remitting multiple sclerosis (2016) (52)
- Microgravity-induced alterations in signal transduction in cells of the immune system (2010) (52)
- IDO (indolamine 2,3-dioxygenase) expression and function in the CNS. (2003) (51)
- Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study (2020) (51)
- Death Ligands and Autoimmune Demyelination (2006) (50)
- In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity (2011) (50)
- Characterizing Microstructural Tissue Properties in Multiple Sclerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design (2019) (49)
- MRI Pattern Recognition in Multiple Sclerosis Normal-Appearing Brain Areas (2011) (49)
- Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis (2007) (49)
- Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study (2004) (49)
- Treatment choices and neuropsychological symptoms of a large cohort of early MS (2018) (48)
- Systemic IFN-β treatment induces apoptosis of peripheral immune cells in MS patients (2003) (47)
- New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis. (2015) (47)
- Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins (2002) (46)
- Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets (2007) (45)
- In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity (2016) (45)
- Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) (2021) (44)
- Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis (2018) (44)
- Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation (2018) (44)
- Gatekeeper role of brain antigen‐presenting CD11c+ cells in neuroinflammation (2016) (44)
- New developments in understanding and treating neuroinflammation (2008) (44)
- Therapeutic targeting of chemokine signaling in Multiple Sclerosis (2008) (43)
- Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis (2013) (43)
- Lamotrigine-antiparkinsonian activity by blockade of glutamate release? (1993) (43)
- Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration (2016) (43)
- Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis (2001) (42)
- IL 12 A , MPHOSPH 9 / CDK 2 AP 1 and RGS 1 are novel multiple sclerosis susceptibility loci (2010) (41)
- Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex (2016) (41)
- Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19 (2021) (41)
- Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study (2016) (40)
- GFAPα IgG-associated encephalitis upon daclizumab treatment of MS (2018) (39)
- Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. (2003) (39)
- Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. (2019) (39)
- MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study (2009) (38)
- Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis (2014) (38)
- Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk (2013) (36)
- Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate (2005) (36)
- Elevated Bcl-XL levels correlate with T cell survival in multiple sclerosis (2002) (36)
- Geranylgeranylation but Not GTP Loading Determines Rho Migratory Function in T Cells1 (2007) (36)
- A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (36)
- Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany (2012) (35)
- Genome-wide significant association with seven novel multiple sclerosis risk loci (2015) (35)
- A woman with acute myelopathy in pregnancy: case outcome (2009) (35)
- Induction of TRAIL-mediated glioma cell death by human T cells (2002) (34)
- FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis (2015) (33)
- Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a. (2007) (33)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (33)
- Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells (2000) (32)
- Multiple sclerosis following etanercept treatment for ankylosing spondylitis (2008) (32)
- Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects (2012) (31)
- Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2 (2017) (31)
- Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis (2004) (31)
- Power estimation for non-standardized multisite studies (2016) (31)
- Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. (1998) (31)
- Roles of the kallikrein/kinin system in the adaptive immune system. (2008) (30)
- Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry (2016) (30)
- Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies? (2013) (30)
- The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients (2015) (29)
- Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity (2020) (29)
- The Role of CD8+ T Cells and Their Local Interaction with CD4+ T Cells in Myelin Oligodendrocyte Glycoprotein35–55–Induced Experimental Autoimmune Encephalomyelitis (2013) (28)
- EGFL7 reduces CNS inflammation in mouse (2018) (28)
- Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development (2016) (28)
- Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2. (2000) (27)
- Ocrelizumab initiation in patients with MS (2020) (27)
- A human post-mortem brain model for the standardization of multi-centre MRI studies (2015) (27)
- Cladribine exerts an immunomodulatory effect on human and murine dendritic cells. (2014) (27)
- Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis (2019) (26)
- Cross-sectional and longitudinal analysis of myelin-reactive T cells in patients with multiple sclerosis (2004) (26)
- SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT (2009) (26)
- Independent replication of STAT3 association with multiple sclerosis risk in a large German case–control sample (2012) (26)
- Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis (2012) (25)
- Dendritic cells as therapeutic targets in neuroinflammation (2016) (25)
- Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS) (2018) (25)
- CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis No differences from normal individuals and no relation to HLA-DR2 (1998) (25)
- Remyelinating strategies in multiple sclerosis (2014) (24)
- A Novel Cervical Spinal Cord Window Preparation Allows for Two-Photon Imaging of T-Cell Interactions with the Cervical Spinal Cord Microvasculature during Experimental Autoimmune Encephalomyelitis (2017) (24)
- No induction of apoptosis by IFN-β in human antigen-specific T cells (2000) (24)
- Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis (2018) (24)
- MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation (2020) (23)
- Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. (2020) (23)
- MANBA , CXCR 5 , SOX 8 , RPS 6 KB 1 and ZBTB 46 are genetic risk loci for multiple sclerosis (2013) (23)
- High-field diffusion tensor imaging of mouse brain in vivo using single-shot STEAM MRI (2007) (22)
- Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopy (2020) (22)
- CCR7 on CD4+ T Cells Plays a Crucial Role in the Induction of Experimental Autoimmune Encephalomyelitis (2018) (22)
- Lamotrigine in Parkinson's disease — a double blind study (1995) (22)
- Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis (2015) (21)
- Cardiotoxicity of Mitoxantrone Treatment in a German Cohort of 639 Multiple Sclerosis Patients (2014) (21)
- Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia. (2012) (21)
- A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes (2009) (21)
- Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans. (2006) (21)
- The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion (2016) (21)
- β1-integrin- and KV1.3 channel-dependent signaling stimulates glutamate release from Th17 cells. (2020) (21)
- MAPK3 deficiency drives autoimmunity via DC arming (2010) (20)
- Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation (2021) (20)
- Dysregulated Epstein-Barr virus infection in patients with CIDP (2010) (20)
- Neuroprotection and enhanced neurogenesis by extract from the tropical plant Knema laurina after inflammatory damage in living brain tissue (2008) (20)
- Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria (2017) (20)
- Regulation of self-reactive T cells by human immunoglobulins--implications for multiple sclerosis therapy. (2003) (19)
- How to treat tumefactive demyelinating disease? (2014) (18)
- Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging. (2016) (18)
- Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis. (2017) (18)
- Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation. (2017) (18)
- Perioperative fluctuations of lamotrigine serum levels in patients undergoing epilepsy surgery (2007) (18)
- The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis (2017) (18)
- Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis (2019) (18)
- Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array (2015) (17)
- Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS (2013) (17)
- Geranylgeranylation but Not GTP-Loading of Rho GTPases Determines T Cell Function (2008) (17)
- A genome-wide German screen for linkage disequilibrium in multiple sclerosis (2003) (17)
- Imaging in mice and men: Pathophysiological insights into multiple sclerosis from conventional and advanced MRI techniques (2019) (17)
- Revised diagnostic criteria for neuromyelitis optica—incorporation of NMO-IgG status (2007) (16)
- Validation of Plasma Branched Chain Amino Acids as Biomarkers in Huntington Disease (2017) (16)
- Investigation of bax, bcl-2, bcl-x and p53 gene polymorphisms in multiple sclerosis (2002) (16)
- Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury (2016) (15)
- A case of recurrent Miller Fisher syndrome mimicking botulism (2006) (15)
- FRET based ratiometric Ca2+ imaging to investigate immune-mediated neuronal and axonal damage processes in experimental autoimmune encephalomyelitis (2015) (15)
- Assessment of microRNA-related SNP effects in the 3′ untranslated region of the IL22RA2 risk locus in multiple sclerosis (2014) (15)
- Bilateral stroke following pituitary apoplexy (2009) (15)
- No induction of apoptosis by IFN-beta in human antigen-specific T cells. (2000) (14)
- Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS (2020) (14)
- Effect of Ceralifimod (ONO-4641), a Sphingosine-1-Phosphate Receptor-1 and -5 Agonist, on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis: Interim Results from the Extension of the DreaMS Study (P3.161) (2014) (14)
- Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis (2015) (14)
- Continuous reorganization of cortical information flow in multiple sclerosis: A longitudinal fMRI effective connectivity study (2020) (14)
- Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment (2017) (13)
- Role of Sortilin in Models of Autoimmune Neuroinflammation (2015) (13)
- CNS-localized myeloid cells capture living invading T cells during neuroinflammation (2020) (13)
- [Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology]. (2011) (13)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2020) (13)
- Treatment-resistant chronic headaches and focal pachymeningitis in a 46-year-old man: a rare presentation of Wegener's granulomatosis (2008) (13)
- Modulation of Dendritic Cell Immunobiology via Inhibition of 3-Hydroxy-3-Methylglutaryl-CoA (HMG-CoA) Reductase (2014) (13)
- NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study (2021) (13)
- Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression (2016) (13)
- Therapieziele von Basis- und Eskalationstherapien zur Behandlung der schubförmig-remittierenden Multiplen Sklerose (2012) (12)
- Targeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity (2018) (12)
- Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS (2019) (12)
- A ‘‘Candidate-Interactome’’ Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis (2013) (12)
- Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS (2020) (12)
- Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug‐resistant epilepsy (2020) (12)
- A “kissing lesion”: In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis (2017) (12)
- PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders (2020) (11)
- A novel automated segmentation method for retinal layers in OCT images proves retinal degeneration after optic neuritis (2015) (11)
- The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis (2016) (11)
- Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis (2007) (11)
- Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders (2021) (11)
- Downregulation of transforming growth factor-β1 in interferon-β1a-treated MS patients (2001) (11)
- Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients (2016) (11)
- Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2 (2021) (10)
- [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. (2016) (10)
- Rhabdomyolysis during interferon-β 1a treatment (2002) (10)
- Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis (2019) (10)
- Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis (2020) (10)
- Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS (2015) (9)
- Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis (2021) (9)
- Neuronal ICAM-5 Plays a Neuroprotective Role in Progressive Neurodegeneration (2019) (9)
- Diagnostik der Multiplen Sklerose 2010 Revision der McDonald-Kriterien (2011) (9)
- Risikostratifizierung einer progressiven multifokalen Leukenzephalopathie unter Natalizumab (2011) (9)
- Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis (2016) (9)
- Glutamine synthetase actiity in patients with Parkinson's disease (1998) (9)
- Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis (2021) (9)
- Rezidivierendes reversibles posteriores Leukenzephalopathiesyndrom unter Chemotherapie mit Cisplatin und 5-Fluorouracil (2006) (9)
- [Neurologic side-effects of pharmacologic corticoid therapy]. (1996) (9)
- Inhibition of the enzyme autotaxin reduces cortical excitability and ameliorates the outcome in stroke (2022) (9)
- Cross-Recognition of a Myelin Peptide by CD8+ T Cells in the CNS Is Not Sufficient to Promote Neuronal Damage (2015) (8)
- Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis (2019) (8)
- Celiac antibodies in the diagnostic workup of white matter lesions (2008) (8)
- Is APOE ε4 associated with cognitive performance in early MS? (2020) (8)
- Two-photon imaging of immune cells in neural tissue. (2013) (8)
- Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis (2021) (8)
- Pooled Analyses from the ALLEGRO and BRAVO Trials on the Safety and Tolerability of Laquinimod as a Multiple Sclerosis Treatment (P04.132) (2012) (7)
- Long-Term Performance of the Bovine Pericardium Patch in Conventional Carotid Endarterectomy (2014) (7)
- Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current treatment strategies? (2018) (7)
- Bilateral meralgia paresthetica after cesarian section with epidural analgesia (2006) (7)
- Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III Trials (S01.007) (2012) (7)
- An Exploratory Analysis of Magnetic Resonance Imaging Outcomes in the DreaMS Trial: A Double-Blind, Placebo-Controlled, Phase 2, 26-Week Trial of a Selective Sphingosine 1-Phosphate Receptor Agonist ONO-4641 in Patients with Relapsing–Remitting Multiple Sclerosis (S31.005) (2013) (7)
- Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS (2013) (7)
- Neurofilament light chain levels reflect outcome in a patient with glutamic acid decarboxylase 65 antibody–positive autoimmune encephalitis under immune checkpoint inhibitor therapy (2021) (6)
- Neuronal Damage in Autoimmune Neuroinflammation Mediated by the Death Ligand TRAIL (2012) (6)
- Cell-cell communication by endocannabinoids during immune surveillance of the central nervous system. (2006) (6)
- Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper) (2021) (6)
- Soluble CD95 (Fas/APO-1) in Malignant Glioma: (No) Implications for CD95-based Immunotherapy? (1998) (6)
- Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry (2020) (6)
- Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study (2021) (6)
- A woman with acute myelopathy in pregnancy: case presentation (2009) (6)
- Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosis. (2019) (6)
- AAN unveils new guidelines for MS disease-modifying therapy (2018) (6)
- Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus (2021) (6)
- Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie (2016) (6)
- [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. (2021) (6)
- AgRP neurons control feeding behaviour at cortical synapses via peripherally derived lysophospholipids (2022) (5)
- Ablagerung von gadoliniumhaltigen Kontrastmitteln im Gehirn nach mehrfacher Anwendung: Konsequenzen für den Einsatz der MRT bei Diagnosestellung und Verlaufsbeurteilung der Multiplen Sklerose? (2016) (5)
- New candidates for CD 4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis (2015) (5)
- Experimental applications of TNF-reporter mice with far-red fluorescent label. (2014) (5)
- Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy (2007) (5)
- Genetic determinants of the humoral immune response in MS (2020) (5)
- Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers (2022) (5)
- Association of obesity with disease outcome in multiple sclerosis (2022) (5)
- Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome. (2019) (5)
- ECTRIMS-EAN clinical practice guideline on pharmacological management of multiple sclerosis. (2016) (5)
- Partial synergy of bisindolylmaleimide with apoptotic stimulus in antigen-specific T cells — implications for multiple sclerosis 1 This work was supported by grants from the DFG, the Hertie-Stiftung and the DMSG. 1 (2000) (4)
- [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. (2019) (4)
- Disease reactivation after switching from natalizumab to daclizumab (2017) (4)
- Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis (2021) (4)
- Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions (2021) (4)
- [Isolated unilateral hypoglossal nerve paralysis in carotid dissection]. (1993) (4)
- Interleukin-4 receptor signaling modulates neuronal network activity (2022) (4)
- Downregulation of transforming growth factor-beta1 in interferon-beta1a-treated MS patients. (2001) (4)
- Effect of the Sphingosine 1-Phosphate Receptor Agonist ONO-4641 on Circulating Lymphocytes in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Phase 2 DreaMS Trial (P05.153) (2013) (4)
- [Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil]. (2006) (4)
- Amendment history : Corrigendum ( June 2015 ) MHCII-independent CD 4 + T cells protect injured CNS neurons via IL-4 (2019) (4)
- Comparison of MRI Criteria for the Diagnosis of Multiple Sclerosis: Role of Cortical Lesions (S45.003) (2016) (4)
- [The genetic profile of multiple sclerosis: risk genes and the "dark matter"]. (2012) (4)
- Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity (2021) (4)
- Neurologische Nebenwirkungen der pharmakologischen Kortikoidtherapie (1996) (4)
- Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose (2021) (4)
- Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose (2021) (4)
- [Influence of genetic factors on multiple sclerosis]. (1996) (4)
- Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement (2020) (4)
- Corrigendum to “Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans” [J. Neuroimmunol. 179 (2006) 108–116] (2007) (4)
- The role of apoptosis in neuroinflammation. (2002) (4)
- Bilateral vertebral artery dissection, agenesis of both ICAs, and connective tissue aberrations (2013) (4)
- DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis (2018) (4)
- A new light source for multimodal multiphoton microscopy including CARS (2009) (4)
- Aktuelle Empfehlungen zu Impfungen bei Multipler Sklerose (2001) (3)
- Putaminal alteration in multiple sclerosis patients with spinal cord lesions (2015) (3)
- Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions (2021) (3)
- Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging (2018) (3)
- Genetic variants associated with intrathecal synthesis of IgG, IgM and IgA in multiple sclerosis (2016) (3)
- Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects (2022) (3)
- Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies. (2022) (3)
- Functional connectivity analysis using whole brain and regional network metrics in MS patients (2016) (3)
- [Current aspects of therapy conversion for multiple sclerosis]. (2015) (3)
- [Recent findings in pathogenesis, diagnostics and therapy of neuromyelitis optica]. (2008) (3)
- Neues zu Pathogenese, Diagnostik und Therapie der Neuromyelitis optica (2008) (3)
- Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis (2009) (3)
- Modulating T cell signaling cascades by HMG-CoA reductase inhibitors (2005) (3)
- No role of IFITM3 in brain tumor formation in vivo (2016) (3)
- A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors (2021) (3)
- Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions (2021) (3)
- Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis (2019) (3)
- The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis (2020) (2)
- Aktuelles zur Therapieumstellung bei Multipler Sklerose (2015) (2)
- Growth-Promoting Treatment Screening for Corticospinal Neurons in Mouse and Man (2020) (2)
- A lymphocyte-glia connection sets the pace for smoldering inflammation (2021) (2)
- Intracranial spreading of a spinal anaplastic astrocytoma (2012) (2)
- A woman with acute myelopathy in pregnancy: case progression (2009) (2)
- Multiple Sklerose Neue therapeutische Strategien im experimentellen Stadium (1997) (2)
- Repository of the Max Delbrück Center for Molecular Medicine (MDC) (2007) (2)
- The frequency of follicular T helper cells differs in acute and chronic neuroinflammation (2020) (2)
- Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis (2013) (2)
- [Multiple sclerosis. New therapeutic strategies in the experimental stage]. (1997) (2)
- [Apoptosis in multiple sclerosis. Etiopathogenetic relevance and prospects for new therapeutic strategies]. (2000) (2)
- Functional connectivity analysis using whole brain and regional network metrics in MS patients (2016) (2)
- High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients (2020) (2)
- Correspondence to Sand et al. “Critical Reappraisal of a Catechol-O-Methyltransferase Transversion Variant in Schizophrenia” (2010) (2)
- The neuroinflammation collection: a vision for expanding neuro-immune crosstalk in Brain (2021) (2)
- Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis (2022) (2)
- No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis. (2011) (2)
- [Current concepts on vaccinations in multiple sclerosis]. (2001) (2)
- Glutamine synthetase activity in patients with Parkinson's disease. (1998) (2)
- [Current recommendations for vaccination in multiple sclerosis]. (2002) (2)
- Apoptose bei multipler Sklerose Ätiopathogenetische Relevanz und Perspektiven für neue therapeutische Strategien (2000) (2)
- Studying the blood–brain barrier will provide new insights into neurodegeneration – Commentary (2018) (1)
- T cell–neuron interaction in inflammatory and progressive multiple sclerosis biology (2022) (1)
- Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis (2021) (1)
- Combined ulnar nerve palsy in Guyon’s canal and distal median nerve irritation following excessive canoeing (2007) (1)
- Cortical Hyperactivity beyond the Immune Attack: Starting Point of Neurodegeneration (S2.002) (2016) (1)
- [Neuroprotection in the treatment of multiple sclerosis]. (2011) (1)
- Progression in multiple sclerosis – a long-term problem (2022) (1)
- MAPK3 deficiency drives autoimmunity via dendritic cell arming (2010) (1)
- Testing different ICA algorithms and connectivity analyses on MS patients (2015) (1)
- Introduction (2007) (1)
- Neuroprotektion in der Therapie der Multiplen Sklerose (2011) (1)
- Aktuelle Empfehlungen zu Impfungen bei Multipler Sklerose (2002) (1)
- Dendritic cells as therapeutic targets in neuroinflammation (2016) (1)
- Preventing disease progression in multiple sclerosis—insights from large real-world cohorts (2022) (1)
- Influence of ultraviolet radiation and diminished-function melanocortin 1 receptor variants on multiple sclerosis disease severity in two large multicenter cohort studies (2019) (1)
- Erratum to: Dendritic cells as therapeutic targets in neuroinflammation (2016) (1)
- An improved anatomical MRI technique with suppression of fixative fluid artifacts for the investigation of human postmortem brain phantoms (2017) (1)
- LifeTime and improving European healthcare through cell-based interceptive medicine (2020) (1)
- Rapid alterations of cell cycle control proteins in human T lymphocytes in microgravity (2012) (1)
- Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose (2019) (1)
- Genetisches Profil der Multiplen Sklerose: Risikogene und die „dunkle Materie“ (2011) (0)
- Neuropsychological impairment in newly diagnosed early multiple sclerosis: clinical and neuropsychological characterization of a German cohort of 1124 patients (2017) (0)
- Reply (1998) (0)
- [New aspects of immunotherapy in multiple sclerosis]. (2018) (0)
- Continuous reorganization of cortical information flow in multiple sclerosis: A longitudinal fMRI effective connectivity study (2020) (0)
- First results of a prospective cohort study in clinically isolated syndromes and early multiple sclerosis of the German Competence Network Multiple Sclerosis (2015) (0)
- [Current therapy of multiple sclerosis: "T-cell vaccination"]. (1994) (0)
- Initial CSF protein predicts treatment response in chronic inmmune mediated demyelinating polyneuropathy (CIP) (2007) (0)
- Baseline Results of the Prospective Nationwide Cohort Study in Clinically Isolated Syndromes and Early Multiple Sclerosis of the German Competence Network Multiple Sclerosis and Monocentric Subgroup Analysis of Neuropsychological Findings (P1.392) (2016) (0)
- Primary progressive multiple sclerosis: evidence for uncoupling disease progression and inflammation (2006) (0)
- Less is more - loss of EGFL7 improves memory by upregulation of VEGF-D (2022) (0)
- Preventing disease progression in multiple sclerosis—insights from large real-world cohorts (2022) (0)
- Erratum to: Dendritic cells as therapeutic targets in neuroinflammation (2016) (0)
- A Novel Cervical Spinal Cord Window Preparation Allows for Two-Photon Imaging of T-Cell Interactions with the Cervical Spinal Cord Microvasculature During EAE (2017) (0)
- Benefits of higher magnetic fields for diffusion tensor imaging ( DTI ) based on single-shot STEAM MRI sequences : In vivo mouse brain studies at 2 . 35 T and 7 T (2005) (0)
- Downregulation of transforming growth factor-&bgr;1 in interferon-&bgr;1a-treated MS patients (2001) (0)
- Cell Cycle Control and Adhesion Molecule Expression in Cells of the Immune System are Sensitive to Altered Gravity (2008) (0)
- Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine (2021) (0)
- Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort (2022) (0)
- Adhesion molecule expression and cell cycle control in cells of the immune system are sensitive to altered gravity (2009) (0)
- Two-photon microscopy and neuroinflammation: Crosstalk between T cells and neurons (2014) (0)
- Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study (2022) (0)
- Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis (2018) (0)
- The role of NFATc2 in chronic autoimmune neuroinflammation (2014) (0)
- Enhanced network activity despite clinical recovery in experimental neuroinflammation using two-photon calcium imaging (2014) (0)
- Interleukin-4 as a therapeutic target. (2023) (0)
- Publisher Correction: Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis (2018) (0)
- Laquinimod Treatment Reduces an Immunogenic Dendritic Cell Population and Protects from Autoimmune CNS Inflammation (P02.117) (2012) (0)
- Peripheral blood cell bulk cultures are not suitable for the analysis of the genetic control of T-cell cytokine function. (2001) (0)
- Casein kinase 2 governs the molecular decision between Th17 cell and Treg cell development and controls encephalitogenicity of Th17 cells in experimental autoimmune encephalomyelitis (2014) (0)
- Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis (2018) (0)
- This information is current as Neuroinflammation Role of Sortilin in Models of Autoimmune Willnow (2015) (0)
- [Milestone or missed opportunity? : Commentary on the revision of the McDonald criteria 2017]. (2019) (0)
- Modulation of human antigen-specific T cell response – therapeutic implications for multiple sclerosis (2003) (0)
- Network alterations underlying anxiety symptoms in early multiple sclerosis (2022) (0)
- Network alterations underlying anxiety symptoms in early multiple sclerosis (2022) (0)
- Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension (2023) (0)
- Intrathecal immunoglobulin synthesis as a predictive marker for disability progression in multiple sclerosis (2017) (0)
- Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort (2018) (0)
- Two-photon imaging of T-cell interactions with the inflamed cervical spinal cord microvasculature (2017) (0)
- Characterization of Th17 cells in multiple sclerosis patients and healthy controls (2014) (0)
- Fully Automated Diagnosis of Multiple Sclerosis based on Pattern Recognition Methods (2009) (0)
- Phosphorylation of ERK1 Atorvastatin Induces T Cell Anergy via (0)
- [Neuroprotective approaches in neurology - dashed hopes?]. (2013) (0)
- Exome Array GWAS in 10,000 Germans Identifies Association between MUC22 and Multiple Sclerosis (2015) (0)
- 11th International Neuroscience Winter Conference Symposium: Neuronal damage and repair in multiple sclerosis (2009) (0)
- Phenotype of Antigen Unexperienced TH Cells in the Inflamed Central Nervous System in Experimental Autoimmune Encephalomyelitis (2016) (0)
- Past, present and future of immunology in Mainz. (2016) (0)
- IL-4 Shapes Microglia-Dependent Pruning of the Cerebellum During Postnatal Development (2022) (0)
- Novel Multiple Sclerosis Genetic Risk Factors Are Involved in Epigenetic Regulation (S37.006) (2016) (0)
- Independent replication of STAT3 association with multiple sclerosis risk in a large German case–control sample (2011) (0)
- Chemokine receptor CCR7 on CD4+ T cells plays a crucial role in the induction of experimental autoimmune encephalomyelitis (2014) (0)
- Inhibiting ERK nuclear translocation in Th17 cells leads to downregulation of GM-CSF (2014) (0)
- EGFL7 reduces CNS inflammation in mouse (2018) (0)
- Assessment of microRNA-related SNP effects in the 3′ untranslated region of the IL22RA2 risk locus in multiple sclerosis (2014) (0)
- Role of extracellular signal-related kinase (Erk) 1 in the regulation of neuroinflammation (2009) (0)
- Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci | NOVA. The University of Newcastle's Digital Repository (2011) (0)
- Potential drug targets for oral medications (2012) (0)
- Publisher Correction: Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis (2018) (0)
- Glial Cells: T Cell Interactions (2009) (0)
- EGFL7 loss correlates with increased VEGF-D expression, upregulating hippocampal adult neurogenesis and improving spatial learning and memory (2023) (0)
- Local self-renewing of microglia is dependent on Interleukin-1 signaling (2015) (0)
- Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories (P1-3.008) (2023) (0)
- Frauke Zipp (2022) (0)
- Selective Detection of NAD(P)H-Dependent Enzymes during Their Function within Vital Cells by means of Time-Resolved TPLSM (2009) (0)
- Draft Cerebral blood perfusion changes in multiple sclerosis (2008) (0)
- Week in The Journal F Cellular / Molecular Close Encounters between T Cells and Neurons (2004) (0)
- Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis (2022) (0)
- Combined ulnar nerve palsy in Guyon's canal and distal median nerve irritation following excessive canoeing (2006) (0)
- Genetic Cell Ablation Reve als Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System Graphical (0)
- Prospective multicenter validation of CSF protein biomarkers in patients with CIS and early MS (2018) (0)
- Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis (2016) (0)
- Means and methods for diagnosis of multiple sclerosis (2010) (0)
- No Evidence for Generation of Th‐2‐like MBP‐Specific T‐Cell Lines by Blockade of the Costimulatory Molecule B7‐1 (2000) (0)
- Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2 (2016) (0)
- Altered grey matter networks in young patients with MS at genetic risk for Alzheimer's disease (2017) (0)
- EGFL7 – a potential therapeutic target for multiple sclerosis? (2018) (0)
- CellsDetermines Rho Migratory Function in T Geranylgeranylation but Not GTP Loading (2007) (0)
- Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosis (2022) (0)
- Editorial Board (2010) (0)
- Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopy (2020) (0)
- Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS (2015) (0)
- Hochdosis-Therapie mit Atorvastatin: gute Verträglichkeit bei Multipler Sklerose auch unter Kombination mit Interferontherapie (2005) (0)
- Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis (2019) (0)
- [Current aspects in discussion of eosinophilia-myalgia syndrome]. (1992) (0)
- Testing direct neuroprotective effects of current MS therapeutic compounds with intravital two photon laser scanning microscopy (2014) (0)
- Accumulation of Gadolinium-based Contrast Agents in the Brain Due to Repetitive Contrast-enhanced MRI: Implications for the Use of MRI in the Diagnosis and Follow-up of Multiple Sclerosis Patients? (2016) (0)
- Phenotype of Antigen Unexperienced TH Cells in the Inflamed Central Nervous System in Experimental Autoimmune Encephalomyelitis (2017) (0)
- Guillain-Barre-Syndrome: current aspects of pathogenesis, diagnosis, and therapy (2007) (0)
- Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study (2015) (0)
- Neuropsychological Symptoms After Anterior Cerebral Artery Ischemic Stroke (2020) (0)
- A method for identifying responsive to IFN-beta multiple sclerosis patients, by determining the expression of Trail (2002) (0)
- Betreuung von Patienten mit multipler Sklerose (2015) (0)
- SFB-TR 128: Multiple Sklerose: Von einem neuen Verständnis der Pathogenese zur Therapie (2013) (0)
- Korrelation fortgeschrittener MR-Techniken (MTR, MRS, DWI) mit immunbiologischer Aktivität und klinischem Status im Frühstadium der Multiplen Sklerose (2004) (0)
- Meilenstein oder verpasste Chance? (2019) (0)
- Kapitel 19 – Neue, experimentelle und zukünftige Therapieansätze (2015) (0)
- Kapitel 17 – Neue, experimentelle und zukünftige Therapieansätze (2006) (0)
- Diagnostik und Therapie des radiologisch isolierten Syndroms (2021) (0)
- Guillain-Barré-Syndrom (2007) (0)
- Myasthenia gravis (2007) (0)
- Neue, experimentelle und zukünftige Therapieansätze (2022) (0)
- Erfahrungswissenschaftliche Evaluierung von 7 ökologischenMilchviehbetrieben mit überdurchschnittlich guten Zellzahlen (2009) (0)
- Vertebral artery dissection as a cause of a pure motor C5/C6 radiculopathy (2010) (0)
- Spinaler Motoneuronverlust in Multipler Sklerose (2007) (0)
- Genetik neuroimmunologischer Erkrankungen (1999) (0)
- Fortschritte in der Neuroimmunologie – Multiple Sklerose (2016) (0)
- Der Einfluss von Entzündungsreaktionen auf die Funktionen des Nervensystems : Graduiertenkolleg der Charité -Universitätsmedizin Berlin (2006) (0)
- Risikomanagement und alltagspraktische Aspekte (2022) (0)
- Kapitel 22 – Betreuung von Patienten mit multipler Sklerose: alltagspraktische Aspekte (2015) (0)
- Multiple Sklerose: Magnetisierungstransfer-Messungen zeigen Erholung der NAWM unter Therapie mit Interferon beta 1a. (2006) (0)
- Autorenverzeichnis (2022) (0)
- Aktuelles zur Behandlung der schubförmigen Multiplen Sklerose (2011) (0)
- Diffuse Blut-Hirn-Schrankenstörung in MRT-Verlaufsuntersuchungen eines Mausmodells der Multiplen Sklerose (aktive experimentelle autoimmune Enzephalomyelitis, EAE) – mögliche Abweichung von Eintrittspforte und Entzündungsherd (2005) (0)
- SFB TRR43: Das Gehirn als Ziel von entzündlichen Prozessen (2008) (0)
- Multiple Sklerose – weit mehr als eine Entmarkungskrankheit (2004) (0)
- Graduiertenkolleg 1258 Der Einfluss von Entzündung auf die Funktion des Nervensystems (2006) (0)
- Neues aus der Immuntherapie bei Multipler Sklerose (2018) (0)
- Kapitel 16 – Pathophysiologisch ansetzende Therapie (2006) (0)
- Neuroprotektive Ansätze in der Neurologie – Enttäuschte Hoffnungen? (2013) (0)
- Neuronale Schädigung bei autoimmuner Demyelinisierung: TRAIL-vermittelte T-Zell-abhängige Apoptose von Neuronen im Mausmodell der Multiplen Sklerose (2005) (0)
- Das Gehirn als Ziel von entzündlichen Prozessen : Sonderforschungsbereich/Transregio TRR 43 (2009) (0)
- Neurodegeneration bei der Multiplen Sklerose (2006) (0)
- Von der Neuroinflammation zur Neurodegeneration (2006) (0)
- Kapitel 20 – Betreuung von Patienten mit Multipler Sklerose: alltagspraktische Aspekte und Rehabilitation (2006) (0)
- Multiple Sklerose: Neue Konzepte zur Immunpathogenese (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Frauke Zipp?
Frauke Zipp is affiliated with the following schools:
